scholarly article | Q13442814 |
P50 | author | Helen E Benson | Q55475662 |
Elena Faccenda | Q55475664 | ||
Joanna L. Sharman | Q55475667 | ||
Christopher Southan | Q28133217 | ||
Michael Spedding | Q42388779 | ||
Adam J Pawson | Q42660485 | ||
Steve Alexander | Q42922475 | ||
Anthony P Davenport | Q43161913 | ||
P2093 | author name string | Anthony J Harmar | |
John A Peters | |||
John C McGrath | |||
NC-IUPHAR | |||
O Peter Buneman | |||
Wenyuan Yu | |||
P2860 | cites work | Novelty in the target landscape of the pharmaceutical industry | Q57338670 |
Open Babel: An open chemical toolbox | Q21198766 | ||
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels | Q24259024 | ||
The Protein Data Bank | Q24515306 | ||
Genenames.org: the HGNC resources in 2013 | Q24595108 | ||
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands | Q24605072 | ||
DrugBank 3.0: a comprehensive resource for 'omics' research on drugs | Q24612505 | ||
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource | Q24632079 | ||
Chemical Entities of Biological Interest: an update | Q24644887 | ||
HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities | Q24675698 | ||
Open PHACTS: semantic interoperability for drug discovery | Q27061937 | ||
Recent Developments of the Chemistry Development Kit (CDK) - An Open-Source Java Library for Chemo- and Bioinformatics | Q27065423 | ||
PubChem: Integrated Platform of Small Molecules and Biological Activities | Q28111978 | ||
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology | Q28189543 | ||
How many drug targets are there? | Q28276660 | ||
Ensembl 2013 | Q28280494 | ||
ChEMBL: a large-scale bioactivity database for drug discovery | Q28315179 | ||
The Rat Genome Database 2013--data, tools and users | Q28677199 | ||
ChemSpider: An Online Chemical Information Resource | Q28842739 | ||
Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds | Q29042705 | ||
IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data | Q29043128 | ||
KEGG for integration and interpretation of large-scale molecular data sets | Q29547277 | ||
ZINC: a free tool to discover chemistry for biology | Q29615857 | ||
Update on activities at the Universal Protein Resource (UniProt) in 2013 | Q29617361 | ||
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature | Q30429523 | ||
IUPHAR-DB: updated database content and new features | Q30485756 | ||
CD-HIT Suite: a web server for clustering and comparing biological sequences | Q33686347 | ||
Trends in the exploitation of novel drug targets | Q34205159 | ||
Guide to Receptors and Channels (GRAC), 5th edition | Q34228968 | ||
The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse | Q35630854 | ||
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. | Q35631111 | ||
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. | Q36747895 | ||
Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database | Q37564801 | ||
New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2. | Q38044984 | ||
The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication | Q38135497 | ||
Mapping between databases of compounds and protein targets | Q38467407 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | Database issue | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
knowledge base | Q593744 | ||
IUPHAR/BPS Guide to PHARMACOLOGY | Q17091219 | ||
P304 | page(s) | D1098-106 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands | |
P478 | volume | 42 |
Q39786582 | 'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models. |
Q34954139 | (4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl] quinoline) is a novel inhibitor of autophagy |
Q36016422 | 15-Lipoxygenases regulate the production of chemokines in human lung macrophages |
Q34619456 | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription |
Q35286427 | 3,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling |
Q41234180 | 3-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo |
Q35223966 | 3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice |
Q43101508 | 4-bromopropofol decreases action potential generation in spinal neurons by inducing a glycine receptor-mediated tonic conductance |
Q42244233 | 5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis |
Q39004681 | 7TM Domain Structure of Adhesion GPCRs |
Q39959758 | 9-Phenanthrol inhibits recombinant and arterial myocyte TMEM16A channels |
Q63869261 | A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data |
Q37318955 | A Cell-type-resolved Liver Proteome |
Q27021865 | A Molecular Pharmacologist's Guide to G Protein-Coupled Receptor Crystallography |
Q35865445 | A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis |
Q39026969 | A comprehensive map of molecular drug targets. |
Q88977270 | A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19 |
Q35865441 | A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia |
Q34571412 | A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis |
Q92376994 | A genome-wide positioning systems network algorithm for in silico drug repurposing |
Q36935210 | A genomic case study of mixed fibrolamellar hepatocellular carcinoma |
Q28647441 | A large-scale crop protection bioassay data set |
Q102371658 | A ligand-based computational drug repurposing pipeline using KNIME and Programmatic Data Access: case studies for rare diseases and COVID-19 |
Q36342127 | A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway |
Q35911730 | A molecular characterization of the agonist binding site of a nematode cys-loop GABA receptor |
Q101406945 | A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 |
Q35305286 | A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors |
Q34516513 | A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells |
Q34914262 | A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice |
Q34954047 | A novel 1,2-benzenediamine derivative FC-99 suppresses TLR3 expression and ameliorates disease symptoms in a mouse model of sepsis |
Q35693015 | A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation |
Q41771681 | A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K |
Q35039225 | A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model |
Q36036244 | A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet |
Q28390721 | A novel mechanism for cytoprotection against hypoxic injury: δ-opioid receptor-mediated increase in Nrf2 translocation |
Q43200676 | A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood. |
Q36941275 | A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance |
Q35538543 | A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability |
Q35911764 | A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury |
Q41295446 | A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier. |
Q28077631 | A review of the new HGNC gene family resource |
Q35692995 | A store-operated calcium channel inhibitor attenuates collagen-induced arthritis |
Q38240756 | A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases |
Q35842234 | A-kinase-anchoring proteins coordinate inflammatory responses to cigarette smoke in airway smooth muscle |
Q35484325 | A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro. |
Q35484505 | AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner |
Q38411332 | APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model |
Q35111465 | AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation |
Q35223957 | AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology |
Q56762858 | Accessing Expert-Curated Pharmacological Data in the IUPHAR/BPS Guide to PHARMACOLOGY |
Q36394989 | Actions of KMUP-1, a xanthine and piperazine derivative, on voltage-gated Na(+) and Ca(2+) -activated K(+) currents in GH3 pituitary tumour cells |
Q36744213 | Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model |
Q36124238 | Activating mitochondrial function and haemoglobin expression with EH-201, an inducer of erythropoietin in neuronal cells, reverses memory impairment |
Q36036213 | Activation of EP4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function |
Q36342084 | Activation of M3 cholinoceptors attenuates vascular injury after ischaemia/reperfusion by inhibiting the Ca2+/calmodulin-dependent protein kinase II pathway |
Q35846222 | Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis |
Q35911725 | Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells |
Q38254275 | Activation of PPARδ: from computer modelling to biological effects. |
Q36342122 | Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function |
Q37686124 | Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches |
Q28611248 | Activity, assay and target data curation and quality in the ChEMBL database |
Q35865452 | Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus |
Q41842140 | Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation |
Q42412786 | Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice. |
Q36744187 | Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo. |
Q36797394 | Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes |
Q36342169 | Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China |
Q36342155 | Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor |
Q35978097 | Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors. |
Q41908015 | Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition. |
Q36342150 | Aldosterone down-regulates the slowly activated delayed rectifier potassium current in adult guinea pig cardiomyocytes |
Q36211232 | Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate. |
Q37686126 | All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway |
Q35978091 | Allosteric modulation of sigma-1 receptors elicits anti-seizure activities |
Q34953389 | Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4. |
Q36124226 | Alterations in perivascular innervation function in mesenteric arteries from offspring of diabetic rats. |
Q42713715 | Alterations in pharmacological and behavioural responses in recombinant mouse line with an increased predisposition to catalepsy: role of the 5-HT1A receptor |
Q36941265 | Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development |
Q28384947 | Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease |
Q42073494 | An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics |
Q35978063 | An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15. |
Q34954063 | An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate. |
Q37591810 | An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti- and proinflammatory effector genes. |
Q109294882 | An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19 |
Q38808034 | An update on PPAR activation by cannabinoids. |
Q26863637 | Anaesthetics as cardioprotectants: translatability and mechanism |
Q43105759 | Analgesic tolerance to morphine is regulated by PPARγ. |
Q35693024 | Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway |
Q36211196 | Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptors |
Q36036207 | Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice |
Q35484382 | Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation |
Q35693008 | Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice |
Q38258912 | Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation. |
Q34619451 | Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice |
Q28652289 | Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist |
Q37084883 | Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction |
Q35693028 | Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy |
Q36830107 | Antinociceptive effects of sinomenine in a rat model of postoperative pain |
Q38802176 | Antioxidant effects of resveratrol in the cardiovascular system. |
Q35631485 | Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors |
Q36903419 | Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity. |
Q99615032 | Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning |
Q27005619 | Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review |
Q36830145 | Aristolochic acid, a plant extract used in the treatment of pain and linked to Balkan endemic nephropathy, is a regulator of K2P channels |
Q36342136 | Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling |
Q35865437 | Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration. |
Q41295868 | Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus |
Q42047360 | Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites |
Q38968834 | Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells |
Q35484237 | Autophagy: an emerging therapeutic target in vascular diseases |
Q37152985 | BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription |
Q46491819 | BJP is changing its requirements for scientific papers to increase transparency. |
Q42594246 | BJP is linking its articles to the IUPHAR/BPS Guide to PHARMACOLOGY. |
Q36903414 | BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice |
Q34423181 | BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice |
Q38825797 | Bcl-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding |
Q36830141 | Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats |
Q36036224 | Betulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-κB- and MAPK-ERK1/2-mediated COX-2 expression |
Q38311702 | Beyond traditional pharmacology: new tools and approaches |
Q34795759 | Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics |
Q30359656 | Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists |
Q36342091 | Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery |
Q38572850 | Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells |
Q35808594 | Bioinformatics-Aided Venomics |
Q38532326 | Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist. |
Q42149597 | Biphasic modulation by mGlu5 receptors of TRPV1-mediated intracellular calcium elevation in sensory neurons contributes to heat sensitivity. |
Q42484273 | Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier |
Q34559598 | Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro |
Q38987933 | CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR |
Q41997418 | CHEMGENIE: integration of chemogenomics data for applications in chemical biology |
Q36546997 | COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link. |
Q42133705 | CREB, AP-1, ternary complex factors and MAP kinases connect transient receptor potential melastatin-3 (TRPM3) channel stimulation with increased c-Fos expression |
Q35223948 | CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779. |
Q43101511 | Calcium affects OX1 orexin (hypocretin) receptor responses by modifying both orexin binding and the signal transduction machinery |
Q35223942 | Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats |
Q38848638 | Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor |
Q38572902 | Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors |
Q38522769 | Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia |
Q30392147 | Carbon nanomaterials combined with metal nanoparticles for theranostic applications |
Q35204828 | Cardiac NO signalling in the metabolic syndrome |
Q35286413 | Caveolins in cardioprotection - translatability and mechanisms |
Q41817045 | Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat. |
Q34953350 | Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1. |
Q36128810 | Cell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to weight-loss |
Q38188055 | Challenges for opioid receptor nomenclature: IUPHAR Review 9. |
Q26773155 | Changes in Membrane Receptors and Ion Channels as Potential Biomarkers for Osteoarthritis |
Q36744172 | Characterization of 12 GnRH peptide agonists - a kinetic perspective |
Q42268714 | Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability. |
Q38240702 | Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. |
Q36578335 | ChemProt-3.0: a global chemical biology diseases mapping |
Q43145398 | Chinese innovation in cardiovascular drug discovery |
Q35865464 | Chloride channels mediate sodium sulphide-induced relaxation in rat uteri |
Q35223960 | Chronic exercise normalizes changes in Cav 1.2 and KCa 1.1 channels in mesenteric arteries from spontaneously hypertensive rats |
Q36394967 | Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis. |
Q36211224 | Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia |
Q36342160 | Class A1 scavenger receptors in cardiovascular diseases |
Q35111476 | Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes. |
Q36032797 | Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery |
Q35223920 | Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice |
Q41819842 | Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis. |
Q36941251 | Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease |
Q38297306 | Combining citrulline with atorvastatin preserves glucose homeostasis in a murine model of diet-induced obesity |
Q47964907 | Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions? |
Q36546985 | Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo |
Q37686141 | Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling |
Q42030632 | Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice. |
Q94554231 | Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors |
Q104151536 | Computational network biology: Data, models, and applications |
Q41892145 | Conformational flexibility of the agonist binding jaw of the human P2X3 receptor is a prerequisite for channel opening |
Q28081462 | Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes |
Q36211201 | Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice |
Q39674678 | Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillation |
Q42099574 | Contribution of adrenomedullin to the switch of G protein-coupled μ-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats |
Q43105830 | Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals |
Q34407185 | Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models |
Q43419090 | Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action |
Q36394992 | Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis. |
Q36342164 | Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1). |
Q64113855 | Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science |
Q28541617 | Cyclin-dependent kinase 5 is involved in the phosphorylation of gephyrin and clustering of GABAA receptors at inhibitory synapses of hippocampal neurons |
Q36797373 | D-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase |
Q36434749 | DGIdb 2.0: mining clinically relevant drug-gene interactions. |
Q38915963 | DHEA modulates the effect of cortisol on RACK1 expression via interference with the splicing of the glucocorticoid receptor |
Q27011914 | DNA demethylation and invasive cancer: implications for therapeutics |
Q37084871 | Daily morphine administration increases impulsivity in rats responding under a 5-choice serial reaction time task |
Q101476452 | Deciphering cell-cell interactions and communication from gene expression |
Q37686138 | Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancers |
Q37084892 | Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach |
Q42559814 | Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. |
Q39157622 | Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis |
Q97552575 | Diabetic nephropathy produces alterations in the tissue expression profile of the orphan receptors GPR149, GPR153, GPR176, TAAR3, TAAR5 and TAAR9 in Wistar rats |
Q36830115 | Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain. |
Q38949654 | Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability |
Q36342144 | Dietary salt regulates epithelial sodium channels in rat endothelial cells: adaptation of vasculature to salt |
Q36744208 | Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al. |
Q34619471 | Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture |
Q35739137 | Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells |
Q35111456 | Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine |
Q35223927 | Differential sensitivity of TREK-1, TREK-2 and TRAAK background potassium channels to the polycationic dye ruthenium red. |
Q36797363 | Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice |
Q35911773 | Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway |
Q36395003 | Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression |
Q35595863 | Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels |
Q36599646 | Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose |
Q35538516 | Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task. |
Q36893893 | Divergent modulation of Rho-kinase and Ca(2+) influx pathways by Src family kinases and focal adhesion kinase in airway smooth muscle. |
Q47951444 | Docking and Virtual Screening in Drug Discovery |
Q43101490 | Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells |
Q28256783 | Dopamine receptors - IUPHAR Review 13 |
Q35692993 | Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells |
Q41295260 | Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1 |
Q36830132 | Drp-1, a potential therapeutic target for brain ischaemic stroke |
Q42551182 | Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modelling |
Q94960045 | Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs |
Q38568763 | Drug-target interaction prediction: databases, web servers and computational models |
Q36507791 | Dynamics of Phosphoinositide-Dependent Signaling in Sympathetic Neurons. |
Q38889914 | Dynasore enhances the formation of mitochondrial antiviral signalling aggregates and endocytosis-independent NF-κB activation |
Q36036258 | Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells |
Q37085527 | Eact, a small molecule activator of TMEM16A, activates TRPV1 and elicits pain- and itch-related behaviours |
Q40625919 | Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia |
Q42552831 | Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease |
Q34939900 | Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord |
Q42412797 | Effect of polyphenolic phytochemicals on ectopic oxidative phosphorylation in rod outer segments of bovine retina |
Q35573896 | Effect of tyrphostin AG879 on Kv 4.2 and Kv 4.3 potassium channels |
Q35846206 | Effective suppression of pro-inflammatory molecules by DHCA via IKK-NF-κB pathway, in vitro and in vivo. |
Q38694069 | Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines |
Q43019107 | Effects of acute and chronic sunitinib treatment on cardiac function and calcium/calmodulin-dependent protein kinase II. |
Q34914328 | Effects of caffeine on circadian phase, amplitude and period evaluated in cells in vitro and peripheral organs in vivo in PER2::LUCIFERASE mice |
Q42114497 | Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling |
Q36903400 | Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes. |
Q35895873 | Effects of new-generation inhibitors of the calcium-activated chloride channel anoctamin 1 on slow waves in the gastrointestinal tract |
Q41432075 | Effects of receptor tyrosine kinase inhibitors on VEGF165 a- and VEGF165 b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2. |
Q37084868 | Effects of the imidazoline I2 receptor agonist 2-BFI on the development of tolerance to and behavioural/physical dependence on morphine in rats |
Q35538521 | Effects of the novel BK (KCa 1.1) channel opener GoSlo-SR-5-130 are dependent on the presence of BKβ subunits |
Q36124232 | Eicosapentaenoic acid prevents TCDD-induced oxidative stress and inflammatory response by modulating MAP kinases and redox-sensitive transcription factors |
Q36342111 | Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases |
Q34559604 | Emodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aorta |
Q35682184 | Enantioselective inhibition of d-serine transport by (S)-ketamine |
Q34953319 | Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey |
Q42107964 | Endocannabinoids modulate human blood-brain barrier permeability in vitro |
Q38235155 | Endothelial atypical cannabinoid receptor: do we have enough evidence? |
Q26767156 | Endothelin |
Q36016411 | Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats |
Q43101498 | Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors. |
Q37084544 | Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species |
Q40559309 | Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2 O2 in resistance arteries from patients with cardiovascular disease |
Q37686147 | Endothelin-1 suppresses insulin-stimulated Akt phosphorylation and glucose uptake via GPCR kinase 2 in skeletal muscle cells |
Q41891837 | Endothelin-converting enzyme 2 differentially regulates opioid receptor activity |
Q28246158 | Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12 |
Q35286438 | Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model |
Q36506903 | Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells |
Q38233723 | Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11. |
Q35631463 | Epigenetics in the perioperative period |
Q35865417 | Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV4 channels |
Q28083604 | Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordance |
Q34954104 | Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile |
Q35223907 | Evidence for annexin A6-dependent plasma membrane remodelling of lipid domains. |
Q47893147 | Evidence-Based Precision Oncology with the Cancer Targetome. |
Q35204841 | Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats |
Q26801615 | Expanding opportunities for mining bioactive chemistry from patents |
Q89875049 | Exploring Integrative Analysis Using the BioMedical Evidence Graph |
Q27021649 | Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS |
Q35286339 | Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? |
Q35111461 | FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation. |
Q36599618 | Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice |
Q37686153 | Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway |
Q28649345 | Finding small molecules for the 'next Ebola' |
Q27021274 | Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5 |
Q37446861 | Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding. |
Q34435307 | Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase. |
Q42926933 | From mouse to man: predicting biased effects of beta-blockers in asthma. |
Q37686113 | Functional, electrophysiological and molecular docking analysis of the modulation of Cav 1.2 channels in rat vascular myocytes by murrayafoline A. |
Q28087460 | Future technology insight: mass spectrometry imaging as a tool in drug research and development |
Q28081099 | G Protein-Coupled Receptor (GPCR) Expression in Native Cells: "Novel" endoGPCRs as Physiologic Regulators and Therapeutic Targets |
Q35538506 | GPCR dimerization in brainstem nuclei contributes to the development of hypertension. |
Q39959829 | GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature |
Q36398022 | GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis. |
Q27005640 | Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors |
Q36599642 | Galanin inhibits GLP-1 and GIP secretion via the GAL1 receptor in enteroendocrine L and K cells |
Q37084887 | Gender-related differential effect of tachykinin NK2 receptor-mediated visceral hyperalgesia in guinea pig colon |
Q28087587 | Generic GPCR residue numbers - aligning topology maps while minding the gaps |
Q36036232 | Genetic deficit of KCa 3.1 channels protects against pulmonary circulatory collapse induced by TRPV4 channel activation. |
Q40834847 | Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin |
Q37686132 | Genipin alleviates sepsis-induced liver injury by restoring autophagy |
Q36342172 | Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice |
Q39090278 | Genomic variant annotation workflow for clinical applications |
Q38921881 | Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain |
Q28067465 | Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes |
Q35538527 | Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. |
Q38974021 | Glutathione administration reduces mitochondrial damage and shifts cell death from necrosis to apoptosis in ageing diabetic mice hearts during exercise |
Q35484483 | Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice |
Q31053398 | Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk |
Q34953430 | Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling |
Q36744223 | High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with the neuromyelitis optica autoantibody, NMO-IgG. |
Q36744177 | High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy |
Q35223938 | High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. |
Q36546975 | High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1. |
Q37005127 | High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice |
Q40160363 | Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo |
Q38264340 | Histamine H₄ receptors in the gastrointestinal tract. |
Q36744218 | Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia |
Q37084539 | Honokiol sensitizes breast cancer cells to TNF-α induction of apoptosis by inhibiting Nur77 expression |
Q92219065 | How to Develop a Drug Target Ontology: KNowledge Acquisition and Representation Methodology (KNARM) |
Q35693003 | HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration |
Q42606979 | Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block. |
Q35484400 | Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells |
Q35846184 | Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand. |
Q42317689 | Hydrogen peroxide activates store-operated Ca(2+) entry in coronary arteries. |
Q34795751 | Hydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signalling |
Q38236845 | Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. |
Q35314338 | Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota. |
Q38564991 | Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management |
Q38808680 | Hypoglycemia unawareness prevention: Targeting glucagon production |
Q34914125 | IL-1β and IL-18: inflammatory markers or mediators of hypertension? |
Q35978086 | IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2. |
Q35865421 | Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels |
Q37084901 | Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. |
Q40954666 | Identification of Histamine H3 Receptor Ligands Using a New Crystal Structure Fragment-based Method. |
Q38833147 | Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors |
Q36744202 | Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase |
Q39909994 | Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation |
Q34402836 | Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer |
Q36016417 | Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target |
Q34447665 | Identification of muscarinic receptor subtypes involved in catecholamine secretion in adrenal medullary chromaffin cells by genetic deletion |
Q34669726 | Identification of novel insulin mimetic drugs by quantitative total internal reflection fluorescence (TIRF) microscopy. |
Q36830137 | Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars |
Q37183342 | Identification of the putative binding pocket of valerenic acid on GABAA receptors using docking studies and site-directed mutagenesis. |
Q38978556 | Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays |
Q38720041 | Identifying ligands at orphan GPCRs: current status using structure-based approaches |
Q35911759 | Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization. |
Q36547012 | Immunoinflammatory diseases of the central nervous system - the tale of two cytokines |
Q36797398 | Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18. |
Q90295510 | In Silico Target Prediction for Small Molecules |
Q47168067 | In silico prediction of chemical mechanism of action via an improved network-based inference method |
Q34571432 | In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives. |
Q35538532 | In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin |
Q34914312 | In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1. |
Q34953409 | In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice |
Q35039228 | Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS |
Q37686319 | Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock. |
Q38263512 | Induction of the inflammatory regulator A20 by gibberellic acid in airway epithelial cells |
Q36546979 | Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice. |
Q36546990 | Inflammation in acute CNS injury: a focus on the role of substance P |
Q42552830 | Inflammation: maladies, models, mechanisms and molecules |
Q35693020 | Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. |
Q41861087 | Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction |
Q35911749 | Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression. |
Q36941262 | Inhibition of fatty acid synthase is protective in pulmonary hypertension |
Q34994542 | Inhibition of monoacylglycerol lipase reduces nicotine withdrawal |
Q40920822 | Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864. |
Q37686101 | Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling |
Q56980193 | Insights into Transporter Classifications: an Outline of Transporters as Drug Targets |
Q41635414 | Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling. |
Q37686098 | Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses. |
Q58104031 | Integrative Data Mining, Scaffold Analysis, and Sequential Binary Classification Models for Exploring Ligand Profiles of Hepatic Organic Anion Transporting Polypeptides (OATPs) |
Q36016439 | Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis. |
Q35111472 | Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel. |
Q41912702 | Interplay between the kinin B1 receptor and inducible nitric oxide synthase in insulin resistance |
Q36941272 | Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits |
Q36830128 | Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis |
Q36599633 | Involvement of Rac1 signalling pathway in the development and maintenance of acute inflammatory pain induced by bee venom injection |
Q35631488 | Involvement of neuronal TGF-β activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord |
Q37084878 | Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol |
Q36599656 | Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries. |
Q92756951 | Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets |
Q34994519 | Ionic mechanisms underlying the negative chronotropic action of propofol on sinoatrial node automaticity in guinea pig heart |
Q40046136 | Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway |
Q27000466 | Ischaemic conditioning: pitfalls on the path to clinical translation |
Q35692999 | Kaempferol enhances endothelium-dependent relaxation in the porcine coronary artery through activation of large-conductance Ca(2+) -activated K(+) channels |
Q34480719 | Ketamine and phencyclidine: the good, the bad and the unexpected |
Q40920574 | Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat. |
Q36533102 | Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines |
Q39116722 | Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors. |
Q39960011 | LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthma |
Q42173694 | Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway |
Q40720078 | Large-Scale Combinatorial Deorphanization of Platynereis Neuropeptide GPCRs |
Q50936162 | Large-scale identification of potential drug targets based on the topological features of human protein-protein interaction network. |
Q57434536 | Ligand-Mediated Toxicology: Characterization and Translational Prospects |
Q34954084 | Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway |
Q35039240 | Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study |
Q27022641 | Localization of α-adrenoceptors: JR Vane Medal Lecture |
Q35978075 | Long-lasting partnership between insulin resistance and endothelial dysfunction: role of metabolic memory. |
Q36744182 | Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity |
Q38825816 | Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor). |
Q40849897 | Luminal 5-HT stimulates colonic bicarbonate secretion in rats |
Q34025135 | Lysophospholipid receptor nomenclature review: IUPHAR Review 8. |
Q38863938 | MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis |
Q42109896 | MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosis |
Q35484424 | MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway |
Q92724567 | Machine learning approaches and databases for prediction of drug-target interaction: a survey paper |
Q36394984 | Macrolides increase the expression of 11β-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa |
Q37686310 | Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon |
Q27943500 | Many InChIs and quite some feat |
Q37685010 | Mapping the function of neuronal ion channels in model and experiment |
Q38809010 | Mass spectrometric analysis of synaptosomal membrane preparations for the determination of brain receptors, transporters and channels |
Q35204865 | Measurement of NO in biological samples |
Q28601949 | Mechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blocker |
Q36016433 | Mechanism of inhibition of mouse Slo3 (KCa 5.1) potassium channels by quinine, quinidine and barium |
Q37686121 | Mechanisms by which the thiazolidinedione troglitazone protects against sucrose-induced hepatic fat accumulation and hyperinsulinaemia |
Q34795689 | Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells |
Q37686103 | Medial prefrontal cortex TRPV1 channels modulate the baroreflex cardiac activity in rats |
Q42107527 | Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of action |
Q36506877 | Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway |
Q35865424 | Meta-chlorophenylpiperazine enhances leptin sensitivity in diet-induced obese mice. |
Q30885784 | Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions |
Q34953372 | Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma |
Q38567309 | Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias |
Q37686108 | Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation |
Q34402820 | Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels. |
Q38692790 | Microglia antioxidant systems and redox signalling |
Q36547001 | Microglial M1/M2 polarization and metabolic states |
Q36546971 | Microglial activation and progressive brain changes in schizophrenia |
Q36506889 | Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade |
Q35223924 | Mitochondrial (dys)function - a factor underlying the variability of efavirenz-induced hepatotoxicity? |
Q41056910 | Model-based prediction of the acute and long-term safety profile of naproxen in rats |
Q36797402 | Molecular and functional characterization of Kv 7 channels in penile arteries and corpus cavernosum of healthy and metabolic syndrome rats. |
Q42088341 | Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies |
Q42554178 | Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants |
Q39062474 | Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2. |
Q36211191 | Molecular dynamics and functional studies define a hot spot of crystal contacts essential for PcTx1 inhibition of acid-sensing ion channel 1a. |
Q42221343 | Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor |
Q42700069 | Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222. |
Q35039217 | Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3. |
Q38597820 | Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure |
Q34914164 | Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus |
Q36599623 | Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17. |
Q43019372 | Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity |
Q34559591 | Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats |
Q35187070 | Multiple roles of the PGE2 -EP receptor signal in vascular permeability |
Q36599662 | N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor |
Q38691764 | NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease |
Q40920604 | NVP-QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia |
Q35851832 | NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function. |
Q40324920 | Natural and synthetic flavonoid modulation of TRPC5 channels |
Q88785856 | Network-Based Disease Module Discovery by a Novel Seed Connector Algorithm with Pathobiological Implications |
Q88973776 | Network-based Drug Repurposing for Human Coronavirus |
Q92872703 | Network-based Prediction of Drug-Target Interactions using an Arbitrary-Order Proximity Embedded Deep Forest |
Q55643995 | Network-based approach to prediction and population-based validation of in silico drug repurposing. |
Q90482543 | Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 |
Q64099168 | Network-based prediction of drug combinations |
Q36744227 | Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis |
Q36394976 | Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats. |
Q37005143 | Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease |
Q34914245 | Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders |
Q35978159 | Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors. |
Q38263507 | Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2. |
Q51210141 | New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies. |
Q38779697 | New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases |
Q35978145 | New selective inhibitors of calcium-activated chloride channels - T16A(inh) -A01, CaCC(inh) -A01 and MONNA - what do they inhibit? |
Q36903409 | New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis. |
Q39674355 | Nicergoline inhibits human platelet Ca(2+) signalling through triggering a microtubule-dependent reorganization of the platelet ultrastructure |
Q91826855 | NicheNet: modeling intercellular communication by linking ligands to target genes |
Q34572211 | Nicotinic acetylcholine receptors control acetylcholine and noradrenaline release in the rodent habenulo-interpeduncular complex |
Q38264366 | Noble gases as cardioprotectants - translatability and mechanism |
Q37084897 | Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma |
Q35111445 | Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits. |
Q36941258 | Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway. |
Q34953338 | Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolonged in vivo glucose-lowering ability |
Q35484363 | Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content |
Q36342131 | Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases |
Q36342140 | Nuciferine relaxes rat mesenteric arteries through endothelium-dependent and -independent mechanisms. |
Q36342177 | Oestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy |
Q38710840 | On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets |
Q35286353 | Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart |
Q38631744 | Optical probes based on G protein-coupled receptors - added work or added value? |
Q34559586 | Orexin A activates hypoglossal motoneurons and enhances genioglossus muscle activity in rats. |
Q35471045 | Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers |
Q38960964 | Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody |
Q34518822 | Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity |
Q92676934 | P2X4 receptors, immunity, and sepsis |
Q34402844 | PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes |
Q36016406 | PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis |
Q100733548 | PIMD: An Integrative Approach for Drug Repositioning Using Multiple Characterization Fusion |
Q43105838 | PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels. |
Q36016445 | PKCε phosphorylates α4β2 nicotinic ACh receptors and promotes recovery from desensitization |
Q35865449 | PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation. |
Q37686110 | PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice |
Q34914220 | PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling |
Q34571380 | Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels |
Q34795735 | Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent |
Q36941269 | Pancreatic polypeptide and its central Y4 receptors are essential for cued fear extinction and permanent suppression of fear |
Q35978108 | Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer |
Q35978127 | Pharmacological actions of nobiletin in the modulation of platelet function. |
Q38909233 | Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channel |
Q34402775 | Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness |
Q36797357 | Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo |
Q36599638 | Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4 |
Q35911768 | Pharmacological inhibition of caspase-8 limits lung tumour outgrowth. |
Q34407191 | Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans. |
Q38915494 | Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo. |
Q35693011 | Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion |
Q34466872 | Pharmacological profile of novel psychoactive benzofurans |
Q35223930 | Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat. |
Q34402759 | Pharmacological regulators of autophagy and their link with modulators of lupus disease |
Q34994550 | Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition |
Q38218546 | Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners |
Q39176672 | Pharmacologically distinct phenotypes of α1B -adrenoceptors: variation in binding and functional affinities for antagonists. |
Q36211219 | Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line |
Q28084793 | Phosphodiesterase 4D: an enzyme to remember |
Q35039202 | Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury |
Q40946825 | Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage |
Q42205768 | Pleiotropic, heart rate-independent cardioprotection by ivabradine. |
Q36797368 | PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase |
Q36599652 | Possible pharmacotherapy for nifedipine-induced gingival overgrowth: 18α-glycyrrhetinic acid inhibits human gingival fibroblast growth |
Q38787139 | Possible role for anisodamine in organophosphate poisoning |
Q27021021 | Postconditioning signalling in the heart: mechanisms and translatability |
Q38752093 | Posttranscriptional regulation of FOXO expression: microRNAs and beyond |
Q34472557 | Potent anti-inflammatory effects of the narrow spectrum kinase inhibitor RV1088 on rheumatoid arthritis synovial membrane cells |
Q34795742 | Preclinical development of AMG 139, a human antibody specifically targeting IL-23 |
Q36094756 | Prediction of compound-target interactions of natural products using large-scale drug and protein information. |
Q90456344 | Prediction of the allergic mechanism of haptens via a reaction-substructure-compound-target-pathway network system |
Q36351777 | Predictive Modeling of Drug Treatment in the Area of Personalized Medicine |
Q28077186 | Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm |
Q35039222 | Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission |
Q36797353 | Presynaptic, release-regulating mGlu2 -preferring and mGlu3 -preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease |
Q34994537 | Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats |
Q35978121 | Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism |
Q36903395 | Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats |
Q36394997 | Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor |
Q36547016 | Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury |
Q35978103 | Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats |
Q36394973 | Propranolol decreases retention of fear memory by modulating the stability of surface glutamate receptor GluA1 subunits in the lateral amygdala |
Q34494513 | Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? |
Q37686116 | Prostaglandin E2 inhibits neutrophil extracellular trap formation through production of cyclic AMP. |
Q38722647 | Protease-activated receptor 4: from structure to function and back again |
Q36797390 | Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway |
Q28606782 | Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism |
Q43200667 | Protective effect of exogenous nitrite in postoperative ileus |
Q38835918 | Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia. |
Q43114230 | Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor. |
Q34795775 | Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells |
Q28647166 | Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection |
Q43101504 | Protons modulate perivascular axo-axonal neurotransmission in the rat mesenteric artery |
Q34402767 | Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies |
Q38972404 | Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel |
Q47407582 | Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches. |
Q35538485 | Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues |
Q34402813 | Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression. |
Q39674704 | Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models. |
Q35978155 | Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells |
Q89674046 | Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics |
Q38693962 | ROS in gastrointestinal inflammation: Rescue Or Sabotage? |
Q35911741 | Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis |
Q35865412 | Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathways |
Q34439244 | Rare platelet GPCR variants: what can we learn? |
Q35978080 | Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2. |
Q35286322 | Redox signalling and cardioprotection: translatability and mechanism |
Q39959986 | Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5. |
Q36342101 | Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice |
Q38802490 | Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside |
Q30384507 | Relief learning is dependent on NMDA receptor activation in the nucleus accumbens |
Q38249023 | Remote conditioning the heart overview: translatability and mechanism |
Q37681996 | Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity |
Q34939968 | Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey. |
Q38829760 | Resveratrol exerts a biphasic effect on apolipoprotein M. |
Q56992819 | Review and comparative assessment of similarity-based methods for prediction of drug–protein interactions in the druggable human proteome |
Q34424009 | Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10. |
Q36211185 | Role for engagement of β-arrestin2 by the transactivated EGFR in agonist-specific regulation of δ receptor activation of ERK1/2. |
Q36797387 | Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension |
Q36796418 | Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2. |
Q35846201 | Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans |
Q37108442 | Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. |
Q26830560 | Role of the MPTP in conditioning the heart - translatability and mechanism |
Q37085532 | Role of the endocannabinoid system in diabetes and diabetic complications |
Q34954019 | Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism |
Q28250152 | Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors |
Q38223040 | S-nitrosation and neuronal plasticity. |
Q42248921 | S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms |
Q36830103 | Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects |
Q35846190 | Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway. |
Q37686096 | Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes |
Q36211215 | Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes |
Q36016427 | Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice |
Q35538502 | Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties |
Q38902193 | Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors. |
Q34914184 | Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmias |
Q37005123 | Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats |
Q35484295 | Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. |
Q40920633 | Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury |
Q34994502 | Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes |
Q51010606 | Selectivity determinants of GPCR-G-protein binding. |
Q35039209 | Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins |
Q35538490 | Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach |
Q36124212 | Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol |
Q40920761 | Short-term variability in QT interval and ventricular arrhythmias induced by dofetilide are dependent on high-frequency autonomic oscillations. |
Q34795714 | Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats. |
Q38247701 | Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future |
Q40695320 | Simulating the influence of plasma protein on measured receptor affinity in biochemical assays reveals the utility of Schild analysis for estimating compound affinity for plasma proteins. |
Q34914140 | Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes |
Q35911736 | Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-β receptor III expression |
Q37686136 | Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice. |
Q28595808 | Size distribution of function-based human gene sets and the split-merge model |
Q34954124 | Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction |
Q35631474 | Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning |
Q34994524 | Sonic hedgehog increases the skin wound-healing ability of mouse embryonic stem cells through the microRNA 200 family |
Q36533318 | Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors |
Q34939936 | Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry |
Q35865460 | Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys |
Q34994554 | Spinal blockage of P/Q- or N-type voltage-gated calcium channels modulates functional and symptomatic changes related to haemorrhagic cystitis in mice. |
Q35484468 | Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure |
Q42700967 | State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine. |
Q34440487 | Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats |
Q35484280 | Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues |
Q28274664 | Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R) |
Q35692991 | Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury |
Q39145769 | Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119. |
Q36336103 | Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening |
Q38877799 | Structural modeling of G-protein coupled receptors: An overview on automatic web-servers |
Q38572969 | Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter |
Q36036218 | Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter |
Q35223902 | Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control |
Q38567235 | Superagonism at G protein-coupled receptors and beyond |
Q35846195 | Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates. |
Q58079602 | Survey of Similarity-based Prediction of Drug-protein Interactions |
Q35484306 | Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21. |
Q36314597 | Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions |
Q38856978 | Synergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells. |
Q35111443 | Synthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives for anticancer activity |
Q34795679 | Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities |
Q34619444 | Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice |
Q41761883 | TRPC6 regulates cell cycle progression by modulating membrane potential in bone marrow stromal cells |
Q43127401 | TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery |
Q35223934 | TRPV4 and K(Ca) ion channels functionally couple as osmosensors in the paraventricular nucleus |
Q34402827 | Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. |
Q38866310 | Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146. |
Q34994532 | Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling |
Q38231327 | Targeting the histone orthography of cancer: drugs for writers, erasers and readers |
Q34994509 | Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept. |
Q26849417 | Ten things you should know about protein kinases: IUPHAR Review 14 |
Q42594000 | Thalamic Kv 7 channels: pharmacological properties and activity control during noxious signal processing |
Q35978150 | The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis |
Q35484349 | The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation |
Q37005139 | The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement |
Q36903392 | The G-protein biased partial κ opioid receptor agonist 6'-GNTI blocks hippocampal paroxysmal discharges without inducing aversion. |
Q35978114 | The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis |
Q42594089 | The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells |
Q89534525 | The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology |
Q28603128 | The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands |
Q47139831 | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. |
Q91135369 | The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY |
Q92999338 | The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases |
Q60950964 | The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension |
Q41374415 | The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives |
Q26770007 | The Warburg effect and drug resistance |
Q41987929 | The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system |
Q41963193 | The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats |
Q37682000 | The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels |
Q35911754 | The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors. |
Q42070708 | The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD. |
Q41865064 | The blockade of transient receptor potential ankirin 1 (TRPA1) signalling mediates antidepressant- and anxiolytic-like actions in mice |
Q40559527 | The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats |
Q38258238 | The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism |
Q38927458 | The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells |
Q34914286 | The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death |
Q38263517 | The contribution of astrocytes and microglia to traumatic brain injury |
Q48347170 | The druggable genome and support for target identification and validation in drug development. |
Q26822987 | The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs |
Q35538511 | The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice |
Q41295964 | The endocannabinoid system in renal cells: regulation of Na(+) transport by CB1 receptors through distinct cell signalling pathways. |
Q37682003 | The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal |
Q35631478 | The endoplasmic reticulum stress and the HIF-1 signalling pathways are involved in the neuronal damage caused by chemical hypoxia. |
Q26801862 | The expanding role of immunopharmacology: IUPHAR Review 16 |
Q34042836 | The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies |
Q37060125 | The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins |
Q36506873 | The high frequency relationship: implications for torsadogenic hERG blockers |
Q36342106 | The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases |
Q35865433 | The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation. |
Q39960078 | The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner |
Q34509746 | The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues. |
Q34953451 | The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptors |
Q34795703 | The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia |
Q36036250 | The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo |
Q41858391 | The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release |
Q36506869 | The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity |
Q35978068 | The opioid receptors as targets for drug abuse medication |
Q35538538 | The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy |
Q28581148 | The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1 |
Q38273378 | The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges. |
Q36903406 | The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying |
Q35111468 | The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects. |
Q36830111 | The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for ("squelching") SRC-1 coactivator |
Q36744197 | The proton-coupled oligopeptide transporter 1 plays a major role in the intestinal permeability and absorption of 5-aminolevulinic acid |
Q34795724 | The role of adenylyl cyclase isoform 6 in β-adrenoceptor signalling in murine airways |
Q28085261 | The role of cannabinoids in adult neurogenesis |
Q26825733 | The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning |
Q38247510 | The role of hexokinase in cardioprotection - mechanism and potential for translation |
Q41762813 | The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue |
Q34939699 | The role of opioid processes in reward and decision-making |
Q27021287 | The role of phosphoinositide-regulated actin reorganization in chemotaxis and cell migration |
Q43119916 | The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood |
Q41958515 | The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination |
Q37686313 | The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma. |
Q36342116 | The virtual heart as a platform for screening drug cardiotoxicity |
Q43127407 | Therapeutic action of 5-HT3 receptor antagonists targeting peritoneal macrophages in post-operative ileus |
Q34427050 | Therapeutic interventions in sepsis: current and anticipated pharmacological agents |
Q35631468 | Therapeutic perspectives of epigenetically active nutrients. |
Q36434850 | Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information |
Q28081591 | Therapeutic targets of triple-negative breast cancer: a review |
Q36830120 | Therapeutic time window for angiotensin-(1-7) in acute lung injury |
Q34419654 | Therapeutic use of botulinum toxin in migraine: mechanisms of action |
Q36506899 | Threonine532 phosphorylation in ClC-3 channels is required for angiotensin II-induced Cl(-) current and migration in cultured vascular smooth muscle cells |
Q37686150 | Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin) |
Q36124220 | Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus |
Q35846211 | Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis |
Q42593944 | Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension |
Q35974649 | Topology based identification and comprehensive classification of four-transmembrane helix containing proteins (4TMs) in the human genome |
Q39034639 | Toward the next step in G protein-coupled receptor research: a knowledge-driven analysis for the next potential targets in drug discovery. |
Q35484265 | Transdermal patches: history, development and pharmacology. |
Q39963734 | Translational mixed-effects PKPD modelling of recombinant human growth hormone - from hypophysectomized rat to patients. |
Q34619478 | Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX. |
Q34914207 | Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation. |
Q36797382 | Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population. |
Q36506880 | Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1 |
Q34994529 | Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors. |
Q38400921 | Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. |
Q34402789 | Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation |
Q38768616 | Ultra-rare genetic variation in common epilepsies: a case-control sequencing study |
Q35161111 | Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm? |
Q28308192 | Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 |
Q35223911 | Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels |
Q38973928 | Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling |
Q35978134 | Validating the GTP-cyclohydrolase 1-feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches |
Q37441534 | Valproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro model |
Q34402797 | Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370 |
Q92355875 | Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz |
Q38927398 | WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages |
Q36124216 | WTC-01, a novel synthetic oxime-flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cells in vitro and in vivo |
Q26998084 | What can isolated skeletal muscle experiments tell us about the effects of caffeine on exercise performance? |
Q38646773 | What is the evidence for the role of TRP channels in inflammatory and immune cells? |
Q46020276 | Why Data Citation Is a Computational Problem. |
Q104213849 | Wikidata as a FAIR knowledge graph for the life sciences |
Q87830400 | Wikidata as a knowledge graph for the life sciences |
Q34795766 | YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells |
Q35865429 | Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activity |
Q35846216 | cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide |
Q27001653 | p38 MAPK in cardioprotection - are we there yet? |
Q35223945 | Δ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells |
Q41373553 | α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95. |
Q42356377 | α1 -Adrenoceptor activation of PKC-ε causes heterologous desensitization of thromboxane receptors in the aorta of spontaneously hypertensive rats |
Q37686129 | α1B -Adrenoceptor signalling regulates bone formation through the up-regulation of CCAAT/enhancer-binding protein δ expression in osteoblasts. |
Q42176718 | α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation |
Q37084535 | β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake |
Q36211207 | β-Blockers have differential effects on the murine asthma phenotype |
Q38849244 | δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine. |
Q41813091 | δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes |
Q35039212 | κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain |
Q34914351 | σ1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain |
Search more.